Back to top

zacks-consensus-estimate: Archive

Zacks Equity Research

Why Is Target (TGT) Down 7.9% Since Last Earnings Report?

Target (TGT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TGTPositive Net Change

Zacks Equity Research

Why Is ZIM (ZIM) Up 3.4% Since Last Earnings Report?

ZIM (ZIM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZIMNegative Net Change

Zacks Equity Research

Why Is Nordson (NDSN) Up 3.5% Since Last Earnings Report?

Nordson (NDSN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NDSNPositive Net Change AITPositive Net Change

Zacks Equity Research

Dycom Industries (DY) Up 3.3% Since Last Earnings Report: Can It Continue?

Dycom Industries (DY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

DYPositive Net Change

Zacks Equity Research

Coty (COTY) Up 12.1% Since Last Earnings Report: Can It Continue?

Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

COTYPositive Net Change NUSPositive Net Change

Zacks Equity Research

Analog Devices (ADI) Up 0.9% Since Last Earnings Report: Can It Continue?

Analog Devices (ADI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ADIPositive Net Change MTSIPositive Net Change

Zacks Equity Research

Wall Street Analysts Think Fiverr (FVRR) Could Surge 26.93%: Read This Before Placing a Bet

The mean of analysts' price targets for Fiverr (FVRR) points to a 26.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

FVRRPositive Net Change

Zacks Equity Research

Does XOMA Royalty (XOMA) Have the Potential to Rally 85.34% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 85.3% in XOMA Royalty (XOMA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

XOMAPositive Net Change

Zacks Equity Research

Earnings Growth & Price Strength Make Micron (MU) a Stock to Watch

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

MUPositive Net Change

Zacks Equity Research

Earnings Growth & Price Strength Make Bank of America (BAC) a Stock to Watch

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

BACPositive Net Change

Zacks Equity Research

Why American Express (AXP) is a Top Stock for the Long-Term

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

AXPPositive Net Change

Zacks Equity Research

Earnings Growth & Price Strength Make Adobe Systems (ADBE) a Stock to Watch

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

ADBEPositive Net Change

Zacks Equity Research

Lennar (LEN) Q3 Earnings and Revenues Lag Estimates

Lennar (LEN) delivered earnings and revenue surprises of -5.66% and -2.49%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

LENPositive Net Change KBHPositive Net Change

Zacks Equity Research

FedEx (FDX) Q1 Earnings and Revenues Beat Estimates

FedEx (FDX) delivered earnings and revenue surprises of +4.93% and +2.15%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

FDXPositive Net Change DALPositive Net Change

Zacks Equity Research

Research Solutions Inc. (RSSS) Q4 Earnings and Revenues Beat Estimates

Research Solutions (RSSS) delivered earnings and revenue surprises of +75.00% and +0.39%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

RSSSPositive Net Change IIINPositive Net Change

Zacks Equity Research

Scholastic (SCHL) Reports Q1 Loss, Misses Revenue Estimates

Scholastic (SCHL) delivered earnings and revenue surprises of -3.28% and -5.57%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

SCHLPositive Net Change MKCPositive Net Change

Zacks Equity Research

Hesai Group Sponsored ADR (HSAI) Upgraded to Buy: Here's What You Should Know

Hesai Group Sponsored ADR (HSAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HSAINegative Net Change

Zacks Equity Research

What Makes iRadimed (IRMD) a New Buy Stock

iRadimed (IRMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

IRMDPositive Net Change

Zacks Equity Research

Magnite (MGNI) Upgraded to Buy: What Does It Mean for the Stock?

Magnite (MGNI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MGNINegative Net Change

Zacks Equity Research

What Makes Advantest (ATEYY) a New Strong Buy Stock

Advantest (ATEYY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ATEYYNegative Net Change

Zacks Equity Research

Sumitomo (SSUMY) Moves to Buy: Rationale Behind the Upgrade

Sumitomo (SSUMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SSUMYPositive Net Change

Zacks Equity Research

Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's Why

Phathom Pharmaceuticals (PHAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PHATPositive Net Change

Zacks Equity Research

Leonardo DRS, Inc. (DRS) Upgraded to Buy: Here's Why

Leonardo DRS, Inc. (DRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

DRSPositive Net Change

Zacks Equity Research

United Bankshares (UBSI) Upgraded to Buy: Here's What You Should Know

United Bankshares (UBSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

UBSIPositive Net Change

Zacks Equity Research

Yext (YEXT) Upgraded to Buy: Here's What You Should Know

Yext (YEXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

YEXTPositive Net Change